Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
2006 1
2009 1
2010 3
2012 1
2013 1
2014 3
2015 2
2016 3
2017 2
2019 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Personal attributes as determinants of timely care in rheumatoid arthritis.
Esselens GH, De Brabander A, Ovaere L, De Brabanter G, Moons P, Westhovens R. Esselens GH, et al. Among authors: de brabanter g. Ann Rheum Dis. 2006 Jul;65(7):967-8. doi: 10.1136/ard.2005.046888. Ann Rheum Dis. 2006. PMID: 16769784 Free PMC article. No abstract available.
Hip involvement in ankylosing spondylitis: epidemiology and risk factors associated with hip replacement surgery.
Vander Cruyssen B, Muñoz-Gomariz E, Font P, Mulero J, de Vlam K, Boonen A, Vazquez-Mellado J, Flores D, Vastesaeger N, Collantes E; ASPECT-REGISPONSER-RESPONDIA working group. Vander Cruyssen B, et al. Rheumatology (Oxford). 2010 Jan;49(1):73-81. doi: 10.1093/rheumatology/kep174. Epub 2009 Jul 14. Rheumatology (Oxford). 2010. PMID: 19605374
An induction or flare of arthritis and/or sacroiliitis by vedolizumab in inflammatory bowel disease: a case series.
Varkas G, Thevissen K, De Brabanter G, Van Praet L, Czul-Gurdian F, Cypers H, De Kock J, Carron P, De Vos M, Hindryckx P, Arts J, Vanneuville I, Schoenaers P, Claerhout B, Abreu M, Van den Bosch F, Elewaut D. Varkas G, et al. Among authors: de brabanter g. Ann Rheum Dis. 2017 May;76(5):878-881. doi: 10.1136/annrheumdis-2016-210233. Epub 2016 Nov 29. Ann Rheum Dis. 2017. PMID: 27899374
Methotrexate in combination with other DMARDs is not superior to methotrexate alone for remission induction with moderate-to-high-dose glucocorticoid bridging in early rheumatoid arthritis after 16 weeks of treatment: the CareRA trial.
Verschueren P, De Cock D, Corluy L, Joos R, Langenaken C, Taelman V, Raeman F, Ravelingien I, Vandevyvere K, Lenaerts J, Geens E, Geusens P, Vanhoof J, Durnez A, Remans J, Vander Cruyssen B, Van Essche E, Sileghem A, De Brabanter G, Joly J, Meyfroidt S, Van der Elst K, Westhovens R. Verschueren P, et al. Among authors: de brabanter g. Ann Rheum Dis. 2015 Jan;74(1):27-34. doi: 10.1136/annrheumdis-2014-205489. Epub 2014 Oct 30. Ann Rheum Dis. 2015. PMID: 25359382 Clinical Trial.
Patients lacking classical poor prognostic markers might also benefit from a step-down glucocorticoid bridging scheme in early rheumatoid arthritis: week 16 results from the randomized multicenter CareRA trial.
Verschueren P, De Cock D, Corluy L, Joos R, Langenaken C, Taelman V, Raeman F, Ravelingien I, Vandevyvere K, Lenaerts J, Geens E, Geusens P, Vanhoof J, Durnez A, Remans J, Vander Cruyssen B, Van Essche E, Sileghem A, De Brabanter G, Joly J, Van der Elst K, Meyfroidt S, Westhovens R; CareRA study group. Verschueren P, et al. Among authors: de brabanter g. Arthritis Res Ther. 2015 Apr 9;17(1):97. doi: 10.1186/s13075-015-0611-8. Arthritis Res Ther. 2015. PMID: 25889222 Free PMC article. Clinical Trial.
14 results